Outsmarting the Heart at ISHLT 2025

At our ISHLT 2025 symposium, a multi-disciplinary faculty discussed unmet needs with guideline directed medical therapy and device therapies in class II/III heart failure patients and reviewed the Barostim implant procedure, clinical data, patient selection, and real world strategies for incorporating Barostim into a comprehensive heart failure program. Watch the presentations to learn more.

Targeting the Neurohormonal Cascade: Impact on Heart Failure Symptoms and Health Care Utilization with Barostim

Nirav Raval, MD

The Team Approach: Integrating Barostim into a Comprehensive Heart Failure Program

Dmitry Yaranov, MD

The Team Approach, Surgical Experience and Heart Failure Collaboration

Eva Proctor, MD

Discussion

Shelley Hall, MD, Nirav Raval, MD, Dmitry Yaranov, MD, and Eva Proctor, MD

Dr. Shelley Hall, Dr. Nirav Raval, Dr. Dmitry Yaranov and Dr. Eva Proctor are paid consultants of CVRx.